A session at the AHA Scientific Sessions 2025 focused on dilemmas related to antithrombotic therapy following catheter ablation in patients with AF.

Data show deep, durable responses in the 50 million cell dose level cohort; initial data suggest substantial early improvement in three patients ...

Cogent Biosciences Inc. (NASDAQ:COGT) surged 12.6% in Monday’s premarket session after unveiling encouraging top-line ...

MaaT013 showed a 62% GI overall response rate at day 28, significantly exceeding historical controls, with durable responses and survival benefits for responders. Safety profile was acceptable, with ...

Treatment with Zervyteg (MaaT013) generated encouraging results and demonstrated an acceptable safety profile in patients with acute graft-vs-host disease that affects the gastrointestinal tract and ...

Research presented at the 2025 ASH Annual Meeting sheds light on serious side effects that appear weeks or months after CAR T cell therapy for multiple myeloma.

General-purpose AI chatbots (e.g., ChatGPT, Claude, Gemini)—designed for broad assistance and conversation, not therapy: They ...

Balance training patients may soon be able to get AI feedback during home exercises, with four wearable sensors and a new ...

Presented in an oral session at the 67th American Society of Hematology Annual Meeting & Exposition ...

We are experiencing a new renaissance…of psychedelic medicine.” By Leah Romero, Source NM New Mexico Department of Health ...

In October 2025, Karolinska Institutet launched a brand-new two-week course giving PhD students a unique insight into how ...

In this interview, George Eastwood, executive director of the Emily Whitehead Foundation and CAR T Vision steering committee member discusses barriers and strategies for expanding access to CAR T-cell ...